• Resources
    • About
    • Events
      • Upcoming Events
      • Archived Events
    • Newsletter
    • Français
  • COVID-19
  • Bloody Easy E-Tools & Publications
    • Bloody Easy Audits
    • Bloody Easy Blood Administration
    • Bloody Easy for Healthcare Professionals
    • Bloody Easy Lite
    • Tech Assess
  • IVIG/SCIG
    • Ordering IG in Ontario
    • Utilization Management Guidelines
    • Dosing Using Adjusted Body Weight
    • Infusion Guide and Adverse Events
    • Facts for Patients
    • Travelling with IG
    • IVIG App
    • Immune Globulin Toolkit
  • Toolkits
    • IVIG
    • Inventory Management
    • Emergency Blood Management
    • Transfusion Committee
    • Special Blood Requirements
    • OTTRM
    • Bedside Audit
    • New Product
    • Dispensary and Administration
    • Transporting Blood Internally
    • Home Infusion Toolkit
    • Resources for Midwives
    • Quality Improvement Plan
    • Transfusion Safety Officer Resource Manual
  • Blood Utilization & Audits
    • Audit Reports
    • Audits - Supporting Documentation
    • Blood Utilization Graphs
    • RBC Benchmarking
    • O Negative RBC Utilization
    • STAT and ASAP Delivery Study
  • TM Guidelines, Standards, & Recommendations
    • Guidelines
    • NAC Guidelines and Recommendations
    • Recommendations
    • Resource Manual for Medical Directors of Transfusion Medicine
    • Standards
  • Massive Hemorrhage Protocol
    • Simulation Videos
    • Toolkit
    • Educational eLearning Modules
    • Recommendations
  • ORBCoN Resources
    • Newsletter
    • Presentation Library
    • Interesting Podcasts
    • Helpful Apps
    • Order Resources
  • Quality Improvement
Home » TM Guidelines, Standards, & Recommendations » Guidelines » Obstetric / Gynaecologic

Obstetric / Gynaecologic

No. 133-Prevention of Rh Alloimmunization

SOGC REAFFIRMED GUIDELINES. No. 133, Reaffirmed January 2018

Visit site

Guideline for blood grouping and red cell antibody testing in pregnancy

BCSH, April 2016.

Visit site

BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn

British Committee for Standards in Haematology, 2014.

View attachment Download
  • TM Guidelines, Standards, & Recommendations

  • Guidelines
    • Anesthesiology
    • Clinical Guides and Physician Handbooks
    • Massive Transfusion
    • Neonates / Pediatric
    • Obstetric / Gynaecologic
    • Plasma
    • Platelets
    • Prothrombin Complex Concentrates
    • Red Cells
  • NAC Guidelines and Recommendations
  • Recommendations
  • Resource Manual for Medical Directors of Transfusion Medicine
    • Table of Contents
    • Introduction
    • 1.0 Medical Roles and Responsibilities
    • 2.0 Quality System Management
    • 3.0 Informed Consent and Refusal of Consent
    • 4.0 Daily Operations
    • 5.0 Appropriate Use of Blood Components for Adults
    • 6.0 Special Product Selection
    • 7.0 Appropriate Use of Manufactured Blood Products
    • 8.0 Appropriate Use of Blood Components in Neonates and Pediatric Patients
    • 9.0 Special Transfusion Situations
    • 10.0 Disaster and Contingency Plans
    • 11.0 Transfusion Reactions
    • References
  • Standards

© 2020 Copyright: Ontario Regional Blood Coordinating Network

    • Contact
    • Useful Links
    • Privacy
    • Legal
Subscribe to our newsletter
    • Contact
    • Useful Links
    • Privacy
    • Legal
Subscribe to our newsletter

© 2020 Copyright: Ontario Regional Blood Coordinating Network